Tag: -1.2%

Biology

AskBio Announces First Patient Dosed with Gene Therapy in Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease

Newsemia
RESEARCH TRIANGLE PARK, N.C. (PRWEB) January 29, 2019 Actus Therapeutics, a privately held portfolio company of Asklepios BioPharmaceutical, Inc. (AskBio), today announced the dosing of...
Pharma / Biotech

TRULICITY (Dulaglutide) Injection, Solution [Eli Lilly And Company]

Newsemia
Updated Date: Jul 13, 2018 EST...
AI/ML

Medicare hits My Health Record opt-out while Health complains about …

Newsemia
2 days ago - My Health Record opt-out was down for less than two hours, while a complaint from the Department of Health has taken...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy